Takeda Pharmaceutical
TAK
#510
Rank
$50.15 B
Marketcap
$15.88
Share price
-2.31%
Change (1 day)
8.21%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for Takeda Pharmaceutical CIK: 0001395064
The 20-F is a 10-K equivalent for non-US companies, as a foreight company Takeda Pharmaceutical only files 20-F reports

Thumbnail Takeda Pharmaceutical 20-F Annual Report

20-F Annual Report 2025-06-25

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report

20-F Annual Report 2024-06-26

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report

20-F Annual Report 2023-06-28

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report

20-F Annual Report 2022-06-29

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report

20-F Annual Report 2021-06-29

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report

20-F Annual Report 2020-06-24

Language: English

View Annual Report (20-F)
Thumbnail Takeda Pharmaceutical 20-F Annual Report

20-F Annual Report 2019-06-27

Language: English

View Annual Report (20-F)